Organization | Unidad Temporal COVID-19 en Centro Citibanamex

Unidad Temporal COVID-19 en Centro Citibanamex Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2020

NCT04570254

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Unidad Temporal COVID-19 en Centro Citibanamex

Active Ingredients

Drugs in Other Trials (5)

acetylcysteine (mucomyst) (1 trial)

melatonin (1 trial)

pentoxifylline (trental) (1 trial)

vitamin c (1 trial)

vitamin e (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 1
# of Trial APIs: 5